Research-Driven Cancer Treatment

Discover our commitment to advancing cancer care and research to offer our patients the latest in research-driven treatments and patient care.

Breakthroughs in cancer research

With more than 900 researchers engaged in cancer research and more than 1,000 clinical trials annually, we are committed to advancing cancer care. The connectivity between our basic and translational research drives breakthroughs in clinical research and care for our patients.

CAR T-cell therapy research at the Maus Lab

Physician-scientists Marcela Maus, MD, PhD, and Matthew Frigault, MD of the Maus Lab are making strides in research on CAR-T-cell therapy for treating cancer.

Read the Q&A

Neutrophil-based immunotherapy for solid tumors

Senior scientist, Tanya Mayadas, PhD, investigates an immune cell called neutrophils to understand its capability to fight cancer, potentially revolutionizing research-driven treatment of solid tumors.

Read the Q&A

Nano-immunotherapy developed to improve lung cancer treatment

Investigators have created a ‘dual action’ treatment that combines immunotherapy with targeted drug delivery and shows promise in preclinical models of lung cancer.

More on this new immunotherapy
Researchers discover role of Pd-1 in driving growth of merkel cell carcinoma

Our investigators recently reported research that has crucial implications for the potential development of new combination therapies for Merkel cell carcinoma.

Learn more about this research
How immunotherapy may change treatment for head and neck cancer patients

Our investigators are conducting clinical trials to answer probing questions on possible applications of immunotherapy in cancer care.

More on the impact of immunotherapy

Confronting brain cancer

Discover how our researchers are working to improve survival rates for patients with brain cancer.

Discover brain cancer research

A person's hands holding a brightly colored plastic model of a brain

Innovative research and clinical care in pancreatic cancer

Discover how our experts are continuing to develop novel strategies for improving outcomes in pancreatic diseases.

Research in pancreatic cancer

Rapid test of cerebrospinal fluid decreases time to diagnosis for brain tumors

A team of neurosurgeons, oncologists, and pathologists came together to create a rapid genotyping test that eliminates the need for invasive surgical biopsy and cuts the time to diagnosis from 10 days to 2.

Learn about the rapid genotype test

In Control Room Doctor and Radiologist Discuss Diagnosis while Watching Procedure and Monitors Showing Brain Scans Results, In the Background Patient Undergoes MRI or CT Scan Procedure.